Health ❯ Healthcare ❯ Clinical Trials

Phase Studies

Phase 2 Studies Rilzabrutinib GO29781 Trial DEVOTE Study Phase II Trials Cardiovascular Diseases LUMINA Studies Edesa Pharmaceuticals Lupus Research Phase-Three Trials Efficacy and Safety GO29781 Study Phase 2/3 Study Tinlarebant

FDA Grants Breakthrough Therapy Designation to Biogen’s Litifilimab for Cutaneous Lupus

The status reflects Phase 2 evidence of reduced skin disease activity in patients with cutaneous lupus erythematosus.

FDA Grants Accelerated Approval to Subcutaneous Lunsumio for Relapsed Follicular Lymphoma

EMA Panel Backs Conditional EU Approval for Anktiva in BCG-Unresponsive Bladder Cancer

EMA Panel Backs Higher-Dose Spinraza for 5q SMA

Veradermics Advances Long-Acting Oral Minoxidil Into Phase 3 U.S. Trials